Author: Matt Mauney

President Donald Trump on Monday signed legislation that will extend the September 11th Victim Compensation Fund until 2092. During the signing ceremony at the White House, Trump was surrounding by first responders, survivors and family members of several who died in the 2001 terrorist attack on the United States. The U.S. House of Representatives and…

The post Trump Signs 9/11 Victims Fund Extension appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Despite banning all forms and uses of asbestos 20 years ago, Great Britain still has one of the world’s highest rates of mesothelioma cancer, according to the government’s Health and Safety Executive report. The July 2019 report revealed the number of annual deaths from mesothelioma in the country still is peaking and expected to begin…

The post Mesothelioma Death Rate Still Rising in Great Britain appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Prophylactic radiotherapy — once offered routinely after invasive procedures for pleural mesothelioma — is an unnecessary treatment for patients, according to the most recent study from the United Kingdom. Results from a large, multicenter clinical trial have shown the treatment — used regularly for almost two decades — does little to prevent chest-wall metastasis that…

The post Radiotherapy No Longer Routine for Mesothelioma Patients appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Specially trained beagles could one day detect mesothelioma by scent, according to the lead researcher of a recent study detailing the dog breed’s stunning accuracy with lung cancer. Dr. Thomas Quinn, clinical professor at the Lake Erie College of Osteopathic Medicine, believes the dogs could be equally effective with pleural mesothelioma, a rare cancer caused…

The post Beagles Diagnosing Cancer ‘Could Work with Mesothelioma’ appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

A research team from France has documented the health-related quality-of-life benefits of adding Avastin (bevacizumab) to chemotherapy for pleural mesothelioma patients, endorsing its addition to standard-of-care treatment. The recent quality-of-life analysis was a secondary endpoint of an earlier, multicenter clinical trial in France that showed an almost three-month median survival improvement when adding Avastin. The…

The post Avastin Improves Quality of Life for Mesothelioma Patients appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

A coalition of attorneys general from 10 states and the District of Columbia has filed a federal lawsuit against the Environmental Protection Agency seeking increased scrutiny on asbestos products. The lawsuit is challenging the EPA’s reluctance to initiate tighter controls or an outright ban of asbestos within the Toxic Substances Control Act, which was revised…

The post States File Lawsuit Against EPA Over Asbestos Regulation appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Almost 50% of the general population in Thailand will die with at least traces of asbestos in their lungs, based on one recent study. Asbestos fibers were discovered in the lungs of 48.5% of those who were part of a one-year, post-mortem analysis done by the Department of Pathology at Ramathibodi Hospital, Mahidol University in…

The post Asbestos Found in Lungs of Half the Thailand Population appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

A research team from the Duke University Medical Center and the Massachusetts Institute of Technology has uncovered a new compound with potential to make chemotherapy more effective in treating various cancers. The small-molecule inhibitor drug — JH-RE-06 — showed an ability to better-sensitize tumors to Cisplatin, the popular chemotherapy drug most often used for mesothelioma…

The post New Compound Could Make Chemotherapy More Effective appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

The influential American Chemistry Council in Washington, D.C., would likely drop its opposition to an across-the-board ban on asbestos provided an exemption remains for the chlor-alkali industry. Mike Walls, ACC vice president for regulatory affairs, clarified his position last month during a congressional Environment and Climate Change subcommittee hearing to discuss the latest legislative effort…

The post Chlor-Alkali Industry Wants Exception to Proposed US Asbestos Ban appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Linda Reinstein was not surprised by the news last week that Colombia had joined the growing list of more than 60 countries to legislate a ban of asbestos. She saw it coming when she spoke on the topic at the University of Rosario in Bogota, Colombia, almost a year ago. She felt the intense passion…

The post Colombia Ban of Asbestos Sets Example for US to Follow appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

As an occupational medicine specialist for more than 30 years, Dr. Michael Harbut has spent much of his career combating asbestos-related disease. Rarely has he felt this energized. Harbut is the lead investigator in a new, high-tech study of breath-based biomarkers that could save lives through novel, early detection of mesothelioma cancer. “This study has…

The post Study Begins to Develop Breath Test for Mesothelioma Early Detection appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

The House Judiciary Committee passed the Never Forget the Heroes bill Wednesday that will extend the 9/11 Victim Compensation Fund until 2090. The bill would ensure all victims of the Sept. 11 terrorist attacks — and their families — will be compensated throughout their lives. It now must pass the full House of Representatives and…

The post Long-Term 9/11 Funding Bill Moves Closer to Reality appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

At the 2019 American Society of Clinical Oncology annual meeting, Dr. Prasad Adusumilli from Memorial Sloan Kettering Cancer Center shared exciting new results from his study on combination immunotherapy for malignant pleural mesothelioma. Among the 18 mesothelioma patients in the study, 14 received a combination of two different immunotherapy treatments. Eleven of this group experienced…

The post Study Combines PD-1 and CAR-T Immunotherapy to Treat Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Too many patients with pleural mesothelioma are going without treatment recommended by National Comprehensive Cancer Network guidelines, according to a recent study at Cedars-Sinai Medical Center in Los Angeles. Valuable survival time is being lost. The Annals of Thoracic Surgery published the study that looked at disparities in compliance with national treatment guidelines and their…

The post Mesothelioma Treatment Guidelines Not Followed Often Enough appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

For the second time in three months, Claire’s stores issued a voluntary recall over concerns of asbestos contamination in its makeup products marketed to young girls, the U.S. Food and Drug Administration announced late Thursday. Claire’s, a children’s fashion accessory retail chain found in malls across the U.S., has recalled its JoJo Siwa Makeup Set…

The post Claire’s Recalls JoJo Siwa Makeup over Asbestos Contamination appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.